Daniel C. Link

Affiliations: 
Biology & Biomedical Sciences (Molecular Cell Biology) Washington University, Saint Louis, St. Louis, MO 
Area:
Molecular Biology
Google:
"Daniel Link"
Cross-listing: Neurotree

BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Abel HJ, Oetjen KA, Miller CA, et al. (2023) Genomic landscape of TP53-mutated myeloid malignancies. Blood Advances
Abel HJ, Oetjen KA, Miller CA, et al. (2023) Genomic landscape of -mutated myeloid malignancies. Medrxiv : the Preprint Server For Health Sciences
Kramer MH, Zhang Q, Sprung R, et al. (2022) Proteomic and Phosphoproteomic Landscapes of Acute Myeloid Leukemia. Blood
Menssen AJ, Khanna A, Miller CA, et al. (2022) Convergent Clonal Evolution of Signaling Gene Mutations Is a Hallmark of Myelodysplastic Syndrome Progression. Blood Cancer Discovery. OF1-OF16
Li S, Yao JC, Oetjen KA, et al. (2022) IL-1b expression in bone marrow dendritic cells is induced by TLR2 agonists and regulates HSC function. Blood
Yao JC, Oetjen KA, Wang T, et al. (2022) TGF-β signaling in myeloproliferative neoplasms contributes to myelofibrosis without disrupting the hematopoietic niche. The Journal of Clinical Investigation
Upadhyay P, Beales J, Shah NM, et al. (2022) Recurrent Transcriptional Responses in AML and MDS patients Treated with Decitabine. Experimental Hematology
Ferraro F, Gruszczynska A, Ruzinova MB, et al. (2022) Decitabine salvage for Tumor Protein P53mutated, relapsed/refractory acute myeloid leukemia after cytotoxic induction therapy. Haematologica
Petti AA, Khan SM, Xu Z, et al. (2022) Genetic and Transcriptional Contributions to Relapse in Normal Karyotype Acute Myeloid Leukemia. Blood Cancer Discovery. 3: 32-49
Wilson ER, Helton NM, Heath SE, et al. (2021) Focal disruption of DNA methylation dynamics at enhancers in IDH-mutant AML cells. Leukemia
See more...